Market revenue in 2023 | USD 263.4 million |
Market revenue in 2030 | USD 507.4 million |
Growth rate | 9.8% (CAGR from 2023 to 2030) |
Largest segment | Botulinum toxin |
Fastest growing segment | Hyaluronic Acid |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hyaluronic Acid, Botulinum Toxin, Aquatic Light Injections |
Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.
Botulinum toxin was the largest segment with a revenue share of 45.75% in 2023. Horizon Databook has segmented the Spain aesthetic injectable market based on hyaluronic acid, botulinum toxin, aquatic light injections covering the revenue growth of each sub-segment from 2018 to 2030.
In Spain, aesthetics is a flourishing industry. The country ranks fifth in Europe in terms of cosmetics and perfume consumption, which can be attributed to increasing aesthetic consciousness.
Moreover, the growing urban population, rising number of novel approved products, easy availability of affordable treatments, rapid advancements in noninvasive procedures, and increasing number of cosmetic professionals are among the factors contributing to the market growth in Spain.
However, the growing number of shipments of unregulated products from Spain is expected to impede international confidence in aesthetic injectables. For instance, in May 2023, more than 70 shipments of unregulated Botox and Juvederm were identified on the U.S. coast, and the products originated from four primary locations: Spain, Bulgaria, China, & South Korea.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain aesthetic injectable market, including forecasts for subscribers. This country databook contains high-level insights into Spain aesthetic injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account